Get started
Author

Minh Nguyen

Granulocyte Macrophage Colony-Stimulating Factor–Secreting Allogeneic Cellular Immunotherapy for Hormone-Refractory Prostate Cancer
2007 · Eric J. Small, Natalie Sacks, et al. · Clinical Cancer Research · 233
CRLX101, a Nanoparticle–Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α
2016 · Xi Tian, Minh Nguyen, et al. · Cancer Research · 90
Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib
2022 · Andrea Loehr, Arif Hussain, et al. · European Urology · 67
PDF
Engineering Antibody Heavy Chain CDR3 to Create a Phage Display Fab Library Rich in Antibodies That Bind Charged Carbohydrates
2008 · Sonia Schoonbroodt, Mieke Steukers, et al. · The Journal of Immunology · 49
PDF
Preclinical Efficacy and Safety Assessment of an Antibody–Drug Conjugate Targeting the c-RET Proto-Oncogene for Breast Carcinoma
2015 · Minh Nguyen, Shuichi Miyakawa, et al. · Clinical Cancer Research · 26
Treatment of Biochemical Recurrence of Prostate Cancer With Granulocyte-Macrophage Colony-Stimulating Factor Secreting, Allogeneic, Cellular Immunotherapy
2008 · Walter J. Urba, John Nemunaitis, et al. · The Journal of Urology · 24
The Multi-Kinase Inhibitor Lucitanib Enhances the Antitumor Activity of Coinhibitory and Costimulatory Immune Pathway Modulators in Syngeneic Models
2022 · Liliane Robillard, Mingxiang Liao, et al. · Journal of Immunotherapy · 7
Identification of antibody responses induced in patients with metastatic hormone-refractory prostate cancer (HRPC) treated with a GM-CSF-transduced allogeneic prostate cancer immunotherapy
2007 · Thomas Harding, Minh Nguyen, et al. · Cancer Research · 2
Liposomal mitomycin C prodrug (Promitil) compared to mitomycin C in chemoradiotherapy in preclinical models of colorectal cancer.
2015 · Xi Tian, Minh Nguyen, et al. · Journal of Clinical Oncology · 1
Improving neoadjuvant chemoradiotherapy for rectal cancer with CRLX101, a nanoparticle-drug conjugate, with a camptothecin payload.
2015 · Andrew Wang, Xi Tian, et al. · Journal of Clinical Oncology · 1
Postnatal gene restoration in succinic semialdehyde dehydrogenase deficiency (SSADHD) reveals phenotype reversibility
2026 · Henry H.C. Lee, Gabrielle McGinty, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Pd16-04 Comparing Surgical Outcomes Prior to and Following Uspstf Psa Downgrade Recommendation
2025 · Minh Nguyen, Dmitry Tumin, et al. · The Journal of Urology
Mp01-02 Trends in Use of Pelvic Lymph Node Dissection During Radical Prostatectomy
2025 · Minh Nguyen, Dmitry Tumin, et al. · The Journal of Urology
Abstract 5515: Neoadjuvant chemoradiotherapy for rectal cancer with CRLX101, an investigational nanoparticle-drug conjugate with a camptothecin payload
2015 · XI TIAN, Minh Nguyen, et al. · Cancer Research
A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy (RT) in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (RP).
2015 · Andrew J. Armstrong, Susan Halabi, et al. · Journal of Clinical Oncology
Abstract 2538: Dendritic and T cell functions in patients with metastatic hormone-refractory prostate cancer treated with GVAX immunotherapy for prostate cancer and ipilimumab
2008 · Saskia J.A.M. Santegoets, Alfons J.M. van den Eertwegh, et al. · Cancer Research
Identification of antibody responses induced in patients with biochemically recurrent and castration-resistant prostate cancer receiving GVAX immunotherapy for prostate cancer
2008 · Kristen Hege, Thomas Harding, et al. · Cancer immunity
Works count: 17
Citation count: 500
H-index: 7
I10-index: 6
Year
Topic
Type